Education
About Us
Working with TipRanks
Follow Us
Keros Therapeutics (KROS)
NASDAQ:KROS
Keros Therapeutics (KROS) Ownership Overview
8.42% Insiders
22.73% Mutual Funds
39.47% Other Institutional Investors
10.18% ETFs
19.21% Public Companies and
Individual Investors
The ownership structure of Keros Therapeutics (KROS) stock is a mix of institutional, retail, and individual investors. Approximately 72.37% of the company’s stock is owned by Institutional Investors, 8.42% is owned by Insiders, and 19.21% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 15, 2024 | Carl Gordon Director, >10% Owner | xxxxxxxxxxxxx | $11002500 |
| Aug 15, 2024 | Orbimed Advisors Llc Director, >10% Owner | xxxxxxxxxxxxx | $11002500 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $182599 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $6137306 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,837,247 | Institution | 4.53% | 21,275,320 | |
| 1,547,178 | Institution | 3.81% | 17,916,321 | |
| 1,505,413 | Institution | 3.71% | 17,432,683 | |
| 1,385,117 | Institution | 3.41% | 16,039,655 | |
| 1,226,412 | Insider | 3.02% | 14,201,851 | |
| 1,226,412 | Insider | 3.02% | 14,201,851 | |
| 905,140 | Institution | 2.23% | 10,481,521 | |
| 664,167 | Institution | 1.64% | 7,691,054 | |
| 649,200 | Institution | 1.60% | 7,517,736 | |
| 575,492 | Insider | 1.42% | 6,664,197 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,547,178 | Institution | 3.81% | 17,916,321 | |
| 1,505,413 | Institution | 3.71% | 17,432,683 | |
| 905,140 | Institution | 2.23% | 10,481,521 | |
| 664,167 | Institution | 1.64% | 7,691,054 | |
| 649,200 | Institution | 1.60% | 7,517,736 | |
| 437,570 | Institution | 1.08% | 5,067,061 | |
| 433,323 | Institution | 1.07% | 5,017,880 | |
| 426,300 | Institution | 1.05% | 4,936,554 | |
| 388,000 | Institution | 0.96% | 4,493,040 | |
| 324,009 | Institution | 0.80% | 3,752,024 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,017,145 | Institution | 2.51% | 11,269,967 | |
| 822,286 | Institution | 2.03% | 9,522,072 | |
| 558,720 | Institution | 1.38% | 6,190,618 | |
| 478,389 | Institution | 1.18% | 5,487,122 | |
| 272,604 | Institution | 0.67% | 3,156,754 | |
| 183,531 | Institution | 0.45% | 2,125,289 | |
| 161,706 | Institution | 0.40% | 1,854,768 | |
| 139,477 | Institution | 0.34% | 1,545,405 | |
| 103,257 | Institution | 0.25% | 1,144,088 | |
| 39,174 | Institution | 0.10% | 453,635 |
FAQ
Who Owns Keros Therapeutics (KROS)?
According to the latest TipRanks data, approximately 39.47% of the company's stock is held by institutional investors, 8.42% is held by insiders, and 19.21% is held by retail investors.
What percentage of Keros Therapeutics (KROS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 39.47% of Keros Therapeutics (KROS) stock is held by institutional investors.
What percentage of Keros Therapeutics (KROS) stock is held by retail investors?
According to the latest TipRanks data, approximately 19.21% of Keros Therapeutics (KROS) stock is held by retail investors.
Who owns the most shares of Keros Therapeutics (KROS)?
Vanguard owns the most shares of Keros Therapeutics (KROS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.